The Effect of Time-restricted Eating on Liver Metabolism

NCT ID: NCT04997486

Last Updated: 2024-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-20

Study Completion Date

2024-03-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Numerous studies have established the role of nutrition on obesity and its related metabolic diseases, which together affect a billion individuals worldwide. Evidence indicate that meal timing regulates numerous metabolic processes suggesting that meal time manipulation may be a simple intervention against obesity and its metabolic diseases. Time-restricted eating (TRE) is a dietary manipulation that involves restricting food intake to 6-10 h/day with no energy intake the rest of the day. In rodents, TRE significantly decreases hepatic steatosis and dyslipidemia, while it supports a healthier hepatic cellular content even without caloric restriction, potentially by alternating activation of nutrient sensing mechanisms and effects on circadian oscillations. However, an understanding of the effect of TRE on liver health in people is not clear. Accordingly, we will conduct a randomized controlled trial in people with overweight/obesity and hepatic steatosis to determine the effect of 9 h TRE for 12 weeks, on key metabolic outcomes in liver health: 1) intrahepatic triglyceride content using magnetic resonance imaging; 2) de novo lipogenesis during fasting and postprandial conditions using administration of deuterated water in conjunction with mathematical modeling. The proposed study will enable us to determine the effect of meal timing on metabolic function in people with NAFLD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

NAFLD Obesity Nutritional and Metabolic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Subjects will consume all meals/snacks during a \~15-h daily eating period (\~9-h fasting). The prescribed energy intake will be monitored and adjusted as needed to achieve weight maintenance.

Group Type NO_INTERVENTION

No interventions assigned to this group

TRE isocaloric

Subjects will consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting). The prescribed energy intake will be monitored and adjusted as needed to achieve weight maintenance.

Group Type EXPERIMENTAL

Time restricted eating

Intervention Type BEHAVIORAL

Participants will be asked consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting).

TRE ad libitum

Subjects will consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting) without any other dietary advice.

Group Type EXPERIMENTAL

Time restricted eating

Intervention Type BEHAVIORAL

Participants will be asked consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Time restricted eating

Participants will be asked consume all meals/snacks during a \~9-h daily eating period (\~15-h fasting).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 25-75 years
* men and women
* body mass index 25-45 kg/m2
* clinical diagnosis of NAFLD
* self-reported habitual eating period more than or equal to 14 h per day.

Exclusion Criteria

* shift worker, recent or expected travel crossing time zones
* fasting \>12-h/day more than once a week

\*\> once a week no food intake after 18:00
* habitually waking up before 04:00 and sleeping before 22:30
* unstable weight (\>5% change in the last 2 months)
* diabetes mellitus or alcoholic liver disease
* sleep disorder
* history of or current eating disorder
* cancer in last 5 years
* conditions that render subject unable to complete all testing procedures
* use of medications that affect the study outcome measures or increase the risk of study procedures and that cannot be temporarily discontinued
* smoking or illegal drug use
* pregnant or breastfeeding
* having metals in the body
* cognitive impairment
* gastrointestinal or bariatric surgery that affects nutrient digestion and absorption unable to grant voluntary informed consent or comply with the study instructions individuals who are not yet adults (infants, children, teenagers)
* individuals that are unable to lie motionless on the MRI scanner for an hour or \*have tattoos or tattooed eyeliner
* alcohol abuse
* prisoners
Minimum Eligible Age

25 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, Davis

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1757716

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Time Restricted Eating in Obese Adults
NCT05660291 ACTIVE_NOT_RECRUITING NA
Timing of Meals for Weight Loss
NCT02204735 COMPLETED NA